Macclesfield, United Kingdom

Nicholas Tomkinson

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 7.3

ph-index = 2

Forward Citations = 18(Granted Patents)


Location History:

  • Loughborough, GB (2008)
  • Macclesfield, GB (2017 - 2024)

Company Filing History:


Years Active: 2008-2024

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: **Nicholas Tomkinson: Pioneering Innovations in Cardiovascular Therapy**

Introduction

Nicholas Tomkinson, an accomplished inventor based in Macclesfield, Great Britain, is recognized for his significant contributions to pharmaceuticals, particularly focused on cardiovascular health. Holding a total of five patents, his work is instrumental in developing therapies that address critical health issues.

Latest Patents

One of Tomkinson's latest innovations involves the compounds known as 1-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-ones, which serve as inhibitors of myeloperoxidase (MPO). These compounds not only encompass the compounds themselves but also their pharmaceutically acceptable salts and associated therapeutic compositions. As inhibitors of the MPO enzyme, these innovative compounds are particularly impactful in treating or preventing cardiovascular disorders, including heart failure and conditions related to coronary artery disease.

Career Highlights

Nicholas Tomkinson's career is anchored at AstraZeneca AB, a leading global biopharmaceutical company renowned for its commitment to developing innovative medicines. His expertise and research have culminated in transformative pharmaceutical products that promise to enhance patient care in cardiovascular therapies.

Collaborations

Throughout his career, Tomkinson has collaborated with esteemed colleagues, including Tord Bertil Inghardt and Petra Johannesson. These partnerships have fostered a creative and productive environment, directly contributing to the successful development of groundbreaking inventions within the pharmaceutical landscape.

Conclusion

Nicholas Tomkinson continues to be a pivotal figure in the field of pharmaceutical innovation. His dedication to developing novel therapeutic compounds demonstrates a profound commitment to addressing critical health challenges in cardiovascular disease. With his impressive patent portfolio, Tomkinson's contributions will undoubtedly leave a lasting impact on the future of medical therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…